SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-069971
Filing Date
2023-06-09
Accepted
2023-06-09 16:59:36
Documents
17
Period of Report
2023-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2317721d5_8k.htm   iXBRL 8-K 35815
2 EXHIBIT 1.1 tm2317721d5_ex1-1.htm EX-1.1 215155
3 EXHIBIT 4.1 tm2317721d5_ex4-1.htm EX-4.1 109926
4 EXHIBIT 4.2 tm2317721d5_ex4-2.htm EX-4.2 107295
5 EXHIBIT 5.1 tm2317721d5_ex5-1.htm EX-5.1 17203
9 GRAPHIC tm2317721d5_ex5-1img001.jpg GRAPHIC 16619
  Complete submission text file 0001104659-23-069971.txt   799961

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA elev-20230608.xsd EX-101.SCH 3060
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE elev-20230608_lab.xml EX-101.LAB 34476
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elev-20230608_pre.xml EX-101.PRE 22613
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2317721d5_8k_htm.xml XML 3721
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40523 | Film No.: 231006139
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences